These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19631585)

  • 41. A new model of induced experimental systemic lupus erythematosus (SLE) in pigs and its amelioration by treatment with a tolerogenic peptide.
    Sharabi A; Dayan M; Zinger H; Mozes E
    J Clin Immunol; 2010 Jan; 30(1):34-44. PubMed ID: 19756988
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS.
    Hong F; Jaruga B; Kim WH; Radaeva S; El-Assal ON; Tian Z; Nguyen VA; Gao B
    J Clin Invest; 2002 Nov; 110(10):1503-13. PubMed ID: 12438448
    [TBL] [Abstract][Full Text] [Related]  

  • 43. IFN-gamma induces apoptosis in developing mast cells.
    Mann-Chandler MN; Kashyap M; Wright HV; Norozian F; Barnstein BO; Gingras S; Parganas E; Ryan JJ
    J Immunol; 2005 Sep; 175(5):3000-5. PubMed ID: 16116187
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.
    Ortiz-Muñoz G; Martin-Ventura JL; Hernandez-Vargas P; Mallavia B; Lopez-Parra V; Lopez-Franco O; Muñoz-Garcia B; Fernandez-Vizarra P; Ortega L; Egido J; Gomez-Guerrero C
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):525-31. PubMed ID: 19164812
    [TBL] [Abstract][Full Text] [Related]  

  • 45. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
    Enghard P; Langnickel D; Riemekasten G
    Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
    [TBL] [Abstract][Full Text] [Related]  

  • 46. JAK inhibitor has the amelioration effect in lupus-prone mice: the involvement of IFN signature gene downregulation.
    Ikeda K; Hayakawa K; Fujishiro M; Kawasaki M; Hirai T; Tsushima H; Miyashita T; Suzuki S; Morimoto S; Tamura N; Takamori K; Ogawa H; Sekigawa I
    BMC Immunol; 2017 Aug; 18(1):41. PubMed ID: 28830352
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SOCS3 negatively regulates IL-6 signaling in vivo.
    Croker BA; Krebs DL; Zhang JG; Wormald S; Willson TA; Stanley EG; Robb L; Greenhalgh CJ; Förster I; Clausen BE; Nicola NA; Metcalf D; Hilton DJ; Roberts AW; Alexander WS
    Nat Immunol; 2003 Jun; 4(6):540-5. PubMed ID: 12754505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. STS-1 promotes IFN-α induced autophagy by activating the JAK1-STAT1 signaling pathway in B cells.
    Dong G; You M; Fan H; Ding L; Sun L; Hou Y
    Eur J Immunol; 2015 Aug; 45(8):2377-88. PubMed ID: 25959715
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polycystic kidneys and chronic inflammatory lesions are the delayed consequences of loss of the suppressor of cytokine signaling-1 (SOCS-1).
    Metcalf D; Mifsud S; Di Rago L; Nicola NA; Hilton DJ; Alexander WS
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):943-8. PubMed ID: 11782537
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transcriptional control of impaired Th1 responses in patent lymphatic filariasis by T-box expressed in T cells and suppressor of cytokine signaling genes.
    Babu S; Kumaraswami V; Nutman TB
    Infect Immun; 2005 Jun; 73(6):3394-401. PubMed ID: 15908366
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interferon-gamma produced by encephalitogenic cells induces suppressors of cytokine signaling in primary murine astrocytes.
    Stark JL; Lyons JA; Cross AH
    J Neuroimmunol; 2004 Jun; 151(1-2):195-200. PubMed ID: 15145618
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interferon-gamma inhibits STAT6 signal transduction and gene expression in human airway epithelial cells.
    Heller NM; Matsukura S; Georas SN; Boothby MR; Rothman PB; Stellato C; Schleimer RP
    Am J Respir Cell Mol Biol; 2004 Nov; 31(5):573-82. PubMed ID: 15297269
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of IFN-gamma resistance is associated with attenuation of SOCS genes induction and constitutive expression of SOCS 3 in melanoma cells.
    Fojtova M; Boudny V; Kovarik A; Lauerova L; Adamkova L; Souckova K; Jarkovsky J; Kovarik J
    Br J Cancer; 2007 Jul; 97(2):231-7. PubMed ID: 17579625
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IFN-gamma down-regulates TGF-beta1-induced IgA expression through Stat1 and p300 signaling.
    Park SR; Jung MH; Jeon SH; Park MH; Park KH; Lee MR; Kim PH
    Mol Cells; 2010 Jan; 29(1):57-62. PubMed ID: 20016942
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A peptide based on the complementarity-determining region 1 of an autoantibody ameliorates lupus by up-regulating CD4+CD25+ cells and TGF-beta.
    Sharabi A; Zinger H; Zborowsky M; Sthoeger ZM; Mozes E
    Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8810-5. PubMed ID: 16735466
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intracellular delivery of a cell-penetrating SOCS1 that targets IFN-gamma signaling.
    DiGiandomenico A; Wylezinski LS; Hawiger J
    Sci Signal; 2009 Jul; 2(80):ra37. PubMed ID: 19622834
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SOCS-3 is downregulated in progressive CKD patients and regulates proliferation in human renal proximal tubule cells in a STAT1/3 independent manner.
    Neuwirt H; Eder IE; Puhr M; Rudnicki M
    Lab Invest; 2013 Jan; 93(1):123-34. PubMed ID: 23108375
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The SOCS-1 story.
    Metcalf D
    Exp Hematol; 1999 Dec; 27(12):1715-23. PubMed ID: 10641589
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhancement of antiviral immunity by small molecule antagonist of suppressor of cytokine signaling.
    Ahmed CM; Dabelic R; Martin JP; Jager LD; Haider SM; Johnson HM
    J Immunol; 2010 Jul; 185(2):1103-13. PubMed ID: 20543109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A peptide based on the complementarity determining region 1 of a human monoclonal autoantibody ameliorates spontaneous and induced lupus manifestations in correlation with cytokine immunomodulation.
    Luger D; Dayan M; Zinger H; Liu JP; Mozes E
    J Clin Immunol; 2004 Nov; 24(6):579-90. PubMed ID: 15622442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.